Provided by Tiger Trade Technology Pte. Ltd.

MannKind

3.75
-0.0400-1.06%
Post-market: 3.750.00000.00%19:59 EDT
Volume:2.47M
Turnover:9.28M
Market Cap:1.21B
PE:-26.79
High:3.85
Open:3.83
Low:3.73
Close:3.79
52wk High:6.51
52wk Low:2.23
Shares:321.54M
Float Shares:309.97M
Volume Ratio:0.67
T/O Rate:0.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1400
EPS(LYR):0.0200
ROE:32.74%
ROA:0.79%
PB:-17.94
PE(LYR):187.50

Loading ...

MannKind Says Phase 1b Study Shows Idiopathic Pulmonary Fibrosis Treatment Generally Safe, Well-Tolerated

MT Newswires Live
·
Jul 29

MannKind Corp - Nintedanib DPI Generally Safe and Well Tolerated in Phase 1B Ipf Study

THOMSON REUTERS
·
Jul 29

MannKind Reports Positive Phase 1B Inflo-1 Results, Demonstrating Safety and Tolerability of Nintedanib DPI and Clinical Validation of Its DPI Technology in Ipf

THOMSON REUTERS
·
Jul 29

MannKind Corp - no Serious Adverse Events or Discontinuations Reported in Phase 1B Inflo-1 Study

THOMSON REUTERS
·
Jul 29

MannKind Reports Positive Phase 1b Inflo-1 Results for Inhaled Nintedanib in IPF

Reuters
·
Jul 29

MannKind to Report Second Quarter Financial Results and Host Conference Call on August 5, 2026

GlobeNewswire
·
Jul 29

Health Rounds: MannKind Injection Helps Heart Failure Patients Avoid ER Infusions

Reuters
·
Jul 29

Analysts Offer Insights on Healthcare Companies: MannKind (MNKD), Bruker (BRKR) and BrightSpring Health Services, Inc. (BTSG)

TIPRANKS
·
Jul 27

The Bull Case For MannKind (MNKD) Could Change Following FDA Approval Of At-Home Furoscix ReadyFlow Autoinjector – Learn Why

Simply Wall St.
·
Jul 25

MannKind Raises $50 Million in Private Placement

TIPRANKS
·
Jul 25

Mannkind Wins FDA Approval for Furoscix Readyflow Autoinjector to Treat Edema in Adults with Heart Failure or CKD

Reuters
·
Jul 25

U.S. Stocks on the Move-booz Allen Hamilton, Sensient, Amkor

Reuters
·
Jul 24

MannKind's Furoscix Auto-Injector Approval, Launch Could Provide Strong Upside to 2026 Revenue Expectation, Wedbush Says

MT Newswires Live
·
Jul 24

Mannkind Corp Shares up 3.4% as FDA Approves Drug-device Combo for Fluid Buildup

THOMSON REUTERS
·
Jul 24

U.S. Stocks on the Move-tenet Healthcare, Intel, Verizon

Reuters
·
Jul 24

MannKind Agrees to $50 Million Private Stock Sale

MT Newswires Live
·
Jul 24

Mannkind Climbs as FDA Approves Drug-device Combo for Fluid Buildup

Reuters
·
Jul 24

MannKind's Furoscix ReadyFlow Injection Approved by US FDA

MT Newswires Live
·
Jul 24

Mannkind Corp Shares up 5.4% Premarket After FDA Approves Co's Single-use Autoinjector to Treat Fluid Buildup

THOMSON REUTERS
·
Jul 24

Mannkind Prices USD 50 Million Private Placement at USD 3.89 Per Share

Reuters
·
Jul 24